GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LivaNova PLC (NAS:LIVN) » Definitions » Shiller PE Ratio
中文

LivaNova (LivaNova) Shiller PE Ratio

: (As of Today)
View and export this data going back to 1993. Start your Free Trial

Shiller PE for Stocks: The True Measure of Stock Valuation


LivaNova Shiller PE Ratio Historical Data

The historical data trend for LivaNova's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LivaNova Annual Data
Trend Apr14 Apr15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 723.37 - - - -

LivaNova Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Medical Devices subindustry, LivaNova's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LivaNova Shiller PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where LivaNova's Shiller PE Ratio falls into.



LivaNova Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

LivaNova's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, LivaNova's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.3/130.0000*130.0000
=0.300

Current CPI (Dec. 2023) = 130.0000.

LivaNova Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201401 0.510 98.700 0.672
201404 0.680 99.600 0.888
201407 0.500 99.600 0.653
201410 0.640 100.100 0.831
201501 0.620 99.200 0.813
201504 0.400 99.900 0.521
201507 0.470 100.000 0.611
201510 -0.960 100.300 -1.244
201603 -0.830 100.400 -1.075
201606 0.180 101.000 0.232
201609 -0.030 101.500 -0.038
201612 -0.610 102.200 -0.776
201703 0.230 102.700 0.291
201706 0.980 103.500 1.231
201709 0.570 104.300 0.710
201712 -2.320 105.000 -2.872
201803 0.270 105.100 0.334
201806 0.310 105.900 0.381
201809 -0.150 106.600 -0.183
201812 -4.340 107.100 -5.268
201903 -0.310 107.000 -0.377
201906 -0.600 107.900 -0.723
201909 0.660 108.400 0.792
201912 -2.960 108.500 -3.547
202003 0.770 108.600 0.922
202006 -1.810 108.800 -2.163
202009 -0.300 109.200 -0.357
202012 -5.750 109.400 -6.833
202103 -0.630 109.700 -0.747
202106 -1.150 111.400 -1.342
202109 -0.840 112.400 -0.972
202112 -0.100 114.700 -0.113
202203 0.060 116.500 0.067
202206 0.300 120.500 0.324
202209 -2.010 122.300 -2.137
202212 0.030 125.300 0.031
202303 0.140 126.800 0.144
202306 0.020 129.400 0.020
202309 -0.140 130.100 -0.140
202312 0.300 130.000 0.300

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


LivaNova  (NAS:LIVN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


LivaNova Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of LivaNova's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LivaNova (LivaNova) Business Description

Traded in Other Exchanges
Address
20 Eastbourne Terrace, London, GBR, W2 6LG
U.K.-based LivaNova was born of a combination between Cyberonics in the U.S. and Sorin in Italy. The medical device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. LivaNova derives roughly half of its revenue from the U.S. market, another 21% from Europe, and the remainder from the rest of the world.
Executives
James Christopher Barry director 7475 LUSK BLVD, SAN DIEGO CA 92121
Damien Mcdonald officer: COO 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Michael Damon Hutchinson officer: Chief Legal Officer 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Brooke Story director C/O SIGILON THERAPEUTICS, INC., 100 BINNEY STREET, SUITE 600, CAMBRIDGE MA 02142
Peter M Wilver director
Daniel Jeffrey Moore director 100 CYBERONICS BVLD, HOUSTON TX 77058
Alfred J Novak director 325 NE 6TH ST, BOCA RATON FL 33432
William A Kozy director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Marco Dolci officer: SVP Global Operations, R&D VIA BENIGNO CRESPI 17, MILAN L6 20159
Todd C Schermerhorn director C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974
Alex Shvartsburg officer: Interim CFO 20 EASTBOURNE TERRACE, LONDON X0 W26LG
Roy Khoury officer: President, International 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY
Thad Allen Huston officer: Chief Financial Officer 941 BLOOMFIELD ST, HOBOKEN NJ 07030
Seng Stacy Enxing director C/O HILL-ROM HOLDINGS, INC., SUITE 4100 180 NORTH STETSON AVENUE, CHICAGO IL 60601
Trui Hebbelinck officer: Chief Human Resources Officer 20 EASTBOURNE TERRACE, LONDON X0 W2 6LG